Public Comment — July 24, 2026

July 24, 2026: MCB Meet­ing July 24, 2026: MCB Agen­da March 27, 2026: MCB Min­utes Carl Olsen: Mr. Olsen expressed sup­port for the Board’s pre­vi­ous rec­om­men­da­tions regard­ing a fed­er­al exemp­tion under 21 U.S.C. § 822(d) and encour­aged con­tin­ued con­sid­er­a­tion of those rec­om­men­da­tions.  He also not­ed his efforts to share the Board’s rec­om­men­da­tions with state and Pub­lic Com­ment — July 24, 2026

Cannabis Rescheduling Confusion

On April 28, 2026, the Attor­ney Gen­er­al of the Unit­ed States, rely­ing on inter­na­tion­al treaties, autho­rized med­ical use of cannabis, but only for state licensed med­ical mar­i­jua­na busi­ness­es that apply for a new fed­er­al reg­is­tra­tion, Final rule, 91 FR 22714.  Hear­ings will be held begin­ning on June 29, 2026 and con­clud­ing not lat­er than July Cannabis Resched­ul­ing Con­fu­sion

Letter to Senate Subcommittee — March 18, 2026

House File 978 — Med­ical Use of Psilo­cy­bin Meet­ing Time: 3/18/26 2:00 PM Loca­tion: Sen­ate Lounge Because psilo­cy­bin is an ille­gal sub­stance under fed­er­al law, House File 978 requires employ­ees to “engage in con­duct which is in vio­la­tion of the crim­i­nal laws of the Unit­ed States.” HF 978 § 4, at page 5, lines 12–21.  Let­ter to Sen­ate Sub­com­mit­tee — March 18, 2026

Letter to Senate Subcommittee — January 24, 2026

House File 978: An Act relat­ing to the pro­duc­tion and admin­is­tra­tion of psilo­cy­bin Meet­ing Time: 1/27/26 1:30 PM Loca­tion: Room 217 Con­fer­ence Room Pub­lic Com­ments Because psilo­cy­bin is an ille­gal sub­stance under fed­er­al law, House File 978 requires employ­ees to “engage in con­duct which is in vio­la­tion of the crim­i­nal laws of the Unit­ed States.” Let­ter to Sen­ate Sub­com­mit­tee — Jan­u­ary 24, 2026

Letter to Senate Subcommittee — Jan. 19, 2026

House File 990 I am writ­ing in sup­port of House File 990, expand­ing access to cannabis for med­ical use, but not on the con­di­tion it puts Iowans into a need­less con­flict with fed­er­al drug law. Please stop autho­riz­ing vio­la­tion of fed­er­al drug law.  Cannabis is a fed­er­al sched­ule 1 con­trolled sub­stance with no accept­ed med­ical Let­ter to Sen­ate Sub­com­mit­tee — Jan. 19, 2026

Letter to the Editor — December 2025

To the Edi­tor: Rick Waga­man’s Guest Opin­ion (Des Moines Reg­is­ter, 12/28/25), “Iowa should be ready for reset on cannabis,” leaves out an impor­tant step Iowa should be tak­ing right now, a fed­er­al waiv­er for Iowa’s med­ical cannabis pro­gram. The board that reg­u­lates the pro­gram has been rec­om­mend­ing a fed­er­al waiv­er since 2019, short­ly after over-the-counter Let­ter to the Edi­tor — Decem­ber 2025

Medical Cannabidiol Board Recommendations 2025

For sev­er­al years now, the Iowa Med­ical Cannabid­i­ol Board has rec­om­mend­ed chang­ing the name “Med­ical Cannabid­i­ol Act” to “Med­ical Cannabis Act” in its annu­al reports to the Iowa Leg­is­la­ture.  The act requires the board to sub­mit annu­al reports to the leg­is­la­ture, Iowa Code § 124E.5(5): On or before Jan­u­ary 1 of each year, begin­ning Jan­u­ary Med­ical Cannabid­i­ol Board Rec­om­men­da­tions 2025

Religious Exceptions to the CSA

The Drug Enforce­ment Admin­is­tra­tion (DEA) cre­at­ed a Guid­ance Doc­u­ment for the Reli­gious Free­dom Restora­tion Act (RFRA) in 2009 which is at the heart of a case argued before the Unit­ed States Court of Appeals for the Dis­trict of Colum­bia Cir­cuit on Novem­ber 14, 2025.  In re: Iowas­ka Church of Heal­ing, No. 25–1140.  The Guid­ance Doc­u­ment Reli­gious Excep­tions to the CSA

Opening Statement — Nov 14, 2025

Good morn­ing your hon­or. Good morn­ing coun­sel. The State has not met its bur­den of demon­strat­ing a com­pelling inter­est in pro­hibit­ing the Petitioner’s pos­ses­sion of cannabis for reli­gious use. The State has the bur­den under the Iowa Reli­gious Free­dom Restora­tion Act to show the Petitioner’s pos­ses­sion of cannabis for reli­gious use is a threat to Open­ing State­ment — Nov 14, 2025

U.S. Attorney General — 2025

Dear Attor­ney Gen­er­al Bon­di: Over the past 10 years two diver­gent paths have emerged for med­ical use of cannabis.  One path, con­sum­able hemp prod­ucts (Iowa Code Chap­ter 204), took a hit last night in the U.S. Sen­ate.  H.R. 5371, Sec­tion 781 (119th Cong. 2025–2026).  The oth­er path, med­ical cannabis (Iowa Code Chap­ter 124E), has been U.S. Attor­ney Gen­er­al — 2025